NM_000492.4:c.3267G>A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000492.4(CFTR):c.3267G>A(p.Trp1089*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000492.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.3267G>A | p.Trp1089* | stop_gained | Exon 20 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:2
- -
The p.W1089* pathogenic mutation (also known as c.3267G>A), located in coding exon 20 of the CFTR gene, results from a G to A substitution at nucleotide position 3266. This changes the amino acid from a tryptophan to a stop codon within coding exon 20. Another nucleotide substitution (c.3266G>A, also known as 3398G>A) resulting in the same protein alteration was originally reported in two non-Ashkenazi Jewish CF patients with pancreatic insufficiency, both of whom had a parent carrying the alteration (Shoshani et al. Hum. Molec. Genet.1994;3:657-658). This pathogenic mutation is associated with pancreatic insufficiency (PI), decreased lung function, and elevated sweat chloride levels (The Clinical and Functional Translation of CFTR (CFTR2); available at http://cftr2.org. Accessed Dec 3, 2014 and Sosnay PR et al. Nat.Genet.2013;45(10):1160-1167). In addition to the clinical data presented in the literature, since premature stop codons are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at